Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Auob Rustamzadeh

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
IBRO Neuroscience Reports|February 5, 2025
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledgeShahram Darabi, Enam Alhagh Charkhat Gorgich, Fatemeh Moradi, et al.
The Neuroradiology Journal|May 21, 2025
Premotor cortex and frontal eye field region metabolite alteration in human amyotrophic lateral sclerosis patients: A quantitative surveyMina Ghannizadeh, Auob Rustamzadeh, Mansour Homayoun, et al.
Journal of Maxillofacial and Oral Surgery|August 4, 2025
Toward Precision Diagnosis of Maxillofacial Pathologies by Artificial Intelligence Algorithms: A Systematic ReviewMeysam Rahmanzadeh, Auob Rustamzadeh, Enam Alhagh Gorgich, et al.
IBRO Neuroscience Reports|September 17, 2025
The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemiaShahram Darabi, Enam Alhagh Gorgich, Auob Rustamzadeh, et al.
IBRO Neuroscience Reports|March 18, 2024
Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer's disease? An umbrella reviewHossein Mohammadi, Armin Ariaei, Zahra Ghobadi, et al.
IBRO Neuroscience Reports|August 14, 2024
Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trialAuob Rustamzadeh, Nader Sadigh, Zahra Vahabi, et al.
Metabolic Brain Disease|June 19, 2024
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort studyFarnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Clinical and Experimental Reproductive Medicine|March 3, 2024
Caffeine attenuates spermatogenic disorders in mice with induced chronic scrotal hyperthermiaAmir Raoofi, Omid Gholami, Hossein Mokhtari, et al.
Tissue & Cell|July 22, 2023
Protective effects of epigallocatechin gallate in the mice induced by chronic scrotal hyperthermiaAmir Raoofi, Melody Omraninava, Roghayeh Javan, et al.
Diagnostic Pathology|March 1, 2024
Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic reviewShahram Darabi, Armin Ariaei, Auob Rustamzadeh, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
IBRO Neuroscience Reports|February 5, 2025
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledgeShahram Darabi, Enam Alhagh Charkhat Gorgich, Fatemeh Moradi, et al.
The Neuroradiology Journal|May 21, 2025
Premotor cortex and frontal eye field region metabolite alteration in human amyotrophic lateral sclerosis patients: A quantitative surveyMina Ghannizadeh, Auob Rustamzadeh, Mansour Homayoun, et al.
Journal of Maxillofacial and Oral Surgery|August 4, 2025
Toward Precision Diagnosis of Maxillofacial Pathologies by Artificial Intelligence Algorithms: A Systematic ReviewMeysam Rahmanzadeh, Auob Rustamzadeh, Enam Alhagh Gorgich, et al.
IBRO Neuroscience Reports|September 17, 2025
The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemiaShahram Darabi, Enam Alhagh Gorgich, Auob Rustamzadeh, et al.
IBRO Neuroscience Reports|March 18, 2024
Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer's disease? An umbrella reviewHossein Mohammadi, Armin Ariaei, Zahra Ghobadi, et al.
IBRO Neuroscience Reports|August 14, 2024
Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trialAuob Rustamzadeh, Nader Sadigh, Zahra Vahabi, et al.
Metabolic Brain Disease|June 19, 2024
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort studyFarnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Clinical and Experimental Reproductive Medicine|March 3, 2024
Caffeine attenuates spermatogenic disorders in mice with induced chronic scrotal hyperthermiaAmir Raoofi, Omid Gholami, Hossein Mokhtari, et al.
Tissue & Cell|July 22, 2023
Protective effects of epigallocatechin gallate in the mice induced by chronic scrotal hyperthermiaAmir Raoofi, Melody Omraninava, Roghayeh Javan, et al.
Diagnostic Pathology|March 1, 2024
Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic reviewShahram Darabi, Armin Ariaei, Auob Rustamzadeh, et al.
Pageof 3